Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Nrc Health filings on SEC EDGAR ↗
NRC Health reported revenue of $38.4 million for the third quarter of 2026, an 11% increase over the prior year, though nine-month operating income fell from $17.9 million to $11.2 million due to higher selling, general, and administrative expenses. The company maintained its quarterly dividend of $0.16 per share while significantly increasing treasury stock repurchases, contributing to a total shareholders' deficit of $9.1 million.
NRC Health returned to double-digit growth in Q3 2026, driven by a major customer implementation and strong performance in Market Insights and Governance Institute segments.
NRC Health reported third-quarter 2026 revenue of $38.4 million, an 11% increase year-over-year, driven by the successful launch of a large customer and multi-year renewals. The company also declared a quarterly cash dividend of $0.16 per share payable in January 2027.
Term
Q3 2026
“We delivered a strong third quarter, with revenue up 11% year-over-year and sequential margin expansion. Our large customer went live on schedule, and several long-standing customers renewed under multi-year agreements, reinforcing the durability of our recurring-revenue base. As our expanding contract base converts into revenue, the operating leverage inherent in our model will translate into greater profitability and free cash flow over time, reinforcing our confidence in NRC Health’s ability to create long-term shareholder value.”
NRC Health has appointed its current CEO, Trent Green, to the additional role of interim principal financial officer effective October 14, 2026. No compensation changes were made in connection with this appointment, and Mr. Green has served as the company's CEO since June 2025.